Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  2. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  3. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  4. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  5. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  6. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  7. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  8. Zaman R, et al. 2021. Immunity. :. PubMed
  9. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  10. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  11. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  12. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  13. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  14. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  15. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  16. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  17. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  18. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  19. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  20. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  21. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  22. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  23. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  24. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  25. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  26. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  27. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  28. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  29. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  30. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  31. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  32. Kim HI, et al. 2022. Molecules. 27: . PubMed
  33. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  34. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  35. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  36. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  37. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  38. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  39. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  40. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  41. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  42. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  43. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  44. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  45. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  46. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  47. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  48. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  49. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  50. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  51. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  52. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  53. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  54. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  55. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  56. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  57. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  58. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  59. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  60. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  61. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  62. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  63. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  64. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  65. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  66. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  67. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  68. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  69. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  70. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  71. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  72. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  73. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  74. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  75. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  76. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  77. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  78. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  79. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  80. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  81. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  82. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  83. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  84. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  85. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  86. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  87. Gawish R, et al. 2022. Elife. 11:. PubMed
  88. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  89. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  90. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  91. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  92. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  93. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  94. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  95. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  96. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  97. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  98. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  99. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  100. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  101. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  102. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  103. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  104. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  105. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  106. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  107. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  108. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  109. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  110. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  111. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  112. Diao L, et al. 2022. iScience. 25:105511. PubMed
  113. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  114. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  115. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  116. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  117. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  118. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  119. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  120. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  121. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  122. Deng P, et al. 2022. Cells. 11:. PubMed
  123. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  124. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  125. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  126. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  127. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  128. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  129. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  130. White C, et al. 2014. J Immunol. 193:5933. PubMed
  131. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  132. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  133. Solanki A, et al. 2018. Development. 145. PubMed
  134. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  135. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  136. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  137. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  138. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  139. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  140. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  141. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  142. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  143. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  144. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  145. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  146. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  147. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  148. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  149. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  150. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  151. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  152. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  153. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  154. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  155. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  156. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  157. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  158. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  159. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  160. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  161. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  162. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  163. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  164. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  165. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  166. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  167. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  168. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  169. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  170. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  171. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  172. Xu X, et al. 2018. Cell. 175:1336. PubMed
  173. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  174. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  175. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  176. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  177. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  178. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  179. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  180. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  181. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  182. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  183. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  184. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  185. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  186. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  187. França TT, et al. 2021. JCI Insight. 6:. PubMed
  188. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  189. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  190. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  191. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  192. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  193. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  194. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  195. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  196. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  197. Port JR, et al. 2020. J Virol. 94:. PubMed
  198. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  199. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  200. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  201. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  202. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  203. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  204. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  205. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  206. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  207. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  208. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  209. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  210. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  211. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  212. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  213. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  214. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  215. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  216. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  217. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  218. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  219. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  220. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  221. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  222. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  223. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  224. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  225. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  226. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  227. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  228. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  229. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  230. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  231. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  232. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  233. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  234. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  235. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  236. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  237. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  238. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  239. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  240. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  241. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  242. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  243. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  244. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  245. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  246. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  247. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  248. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  249. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  250. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  251. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  252. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  253. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  254. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  255. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  256. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  257. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  258. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  259. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  260. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  261. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  262. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  263. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  264. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  265. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  266. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  267. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  268. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  269. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  270. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  271. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  272. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  273. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  274. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  275. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  276. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  277. Tao Z, et al. 2022. Cells. 11:. PubMed
  278. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  279. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  280. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  281. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  282. Zheng Y, et al. 2022. Transl Res. :. PubMed
  283. Gawish R, et al. 2022. Elife. 11:. PubMed
  284. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  285. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  286. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  287. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  288. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  289. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  290. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  291. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  292. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  293. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  294. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  295. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  296. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  297. Li J, et al. 2021. eLife. 10:00. PubMed
  298. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  299. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  300. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  301. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  302. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  303. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  304. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
Test 17A2 5 17A2
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account